1,4-Benzodiazepines with 5-and 6-membered heterocyclic rings
申请人:Merck & Co., Inc.
公开号:EP0272865A1
公开(公告)日:1988-06-29
Aromatic 1,4-benxodiazepines with fused 5-or 6-membered heterocyclic rings which are antagonists of cholecystokinins and/or gastrin, and are useful in the treatment or prevention of CCK-related and/or gastrin-related disorders of the gastrointestinal, central nervous and appetite regulatory systems; compositions comprising these compounds; and methods of treatment employing these compounds.
1,4-Benzodiazepines condesed with 5- and 6-membered heterocyclic rings to treat anxiety, pain, pupil constriction, withdrawal-syndrome or oncologic disorders
申请人:MERCK & CO. INC.
公开号:EP0518484A2
公开(公告)日:1992-12-16
Pharmaceutical compositions containing compounds of the formula (I)
wherein Y = CH2, N-R1 or is absent, and Z = N or CH2, are useful in the treatment of panic or anxienty, pain pupil constriction of the eye or withdrawal response produced by chronic treatment or abuse of drugs or alcohol.
含有式 (I) 化合物的药物组合物
其中 Y = CH2、N-R1 或不存在,Z = N 或 CH2,可用于治疗因长期治疗或滥用药物或酒精而产生的恐慌或焦虑、眼睛疼痛瞳孔收缩或戒断反应。
US4735941A
申请人:——
公开号:US4735941A
公开(公告)日:1988-04-05
1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as
申请人:Merck & Co., Inc.
公开号:US04735941A1
公开(公告)日:1988-04-05
Aromatic 1,4-benxodiazepines with fused 5- or 6-membered heterocyclic rings which are antagonists of cholecystokinins and/or gastrin, and are useful in the treatment or prevention of CCK-related and/or gastrin-related disorders of the gastrointestinal, central nervous and appetite regulatory systems; compositions comprising these compounds; and methods of treatment employing these compounds.